 Connection
Edward Havranek to Risk Assessment
This is a "connection" page, showing publications Edward Havranek has written about Risk Assessment.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.364 |
|
|
|
-
Havranek EP, Emsermann CD, Froshaug DN, Masoudi FA, Krantz MJ, Hanratty R, Estacio RO, Dickinson LM, Steiner JF. Thresholds in the relationship between mortality and left ventricular hypertrophy defined by electrocardiography. J Electrocardiol. 2008 Jul-Aug; 41(4):342-50.
Score: 0.160
-
Pflederer MC, Long CS, Beaty B, Havranek EP, Mehler PS, Keniston A, Krantz MJ. Longitudinal Changes in Vascular Risk Markers and Mortality Rates among a Latino Population with Hypertension. Tex Heart Inst J. 2016 Apr; 43(2):131-6.
Score: 0.070
-
Hurley LP, Dickinson LM, Estacio RO, Steiner JF, Havranek EP. Prediction of cardiovascular death in racial/ethnic minorities using Framingham risk factors. Circ Cardiovasc Qual Outcomes. 2010 Mar; 3(2):181-7.
Score: 0.046
-
Perman SM, Shelton SK, Knoepke C, Rappaport K, Matlock DD, Adelgais K, Havranek EP, Daugherty SL. Public Perceptions on Why Women Receive Less Bystander Cardiopulmonary Resuscitation Than Men in Out-of-Hospital Cardiac Arrest. Circulation. 2019 02 19; 139(8):1060-1068.
Score: 0.021
-
Martin SS, Faridi KF, Joshi PH, Blaha MJ, Kulkarni KR, Khokhar AA, Maddox TM, Havranek EP, Toth PP, Tang F, Spertus JA, Jones SR. Remnant Lipoprotein Cholesterol and Mortality After Acute Myocardial Infarction: Further Evidence for a Hypercholesterolemia Paradox From the TRIUMPH Registry. Clin Cardiol. 2015 Nov; 38(11):660-7.
Score: 0.017
-
Schroeder EB, Hanratty R, Beaty BL, Bayliss EA, Havranek EP, Steiner JF. Simultaneous control of diabetes mellitus, hypertension, and hyperlipidemia in 2 health systems. Circ Cardiovasc Qual Outcomes. 2012 Sep 01; 5(5):645-53.
Score: 0.014
-
Hanratty R, Chonchol M, Havranek EP, Powers JD, Dickinson LM, Ho PM, Magid DJ, Steiner JF. Relationship between blood pressure and incident chronic kidney disease in hypertensive patients. Clin J Am Soc Nephrol. 2011 Nov; 6(11):2605-11.
Score: 0.013
-
Masoudi FA, Gross CP, Wang Y, Rathore SS, Havranek EP, Foody JM, Krumholz HM. Adoption of spironolactone therapy for older patients with heart failure and left ventricular systolic dysfunction in the United States, 1998-2001. Circulation. 2005 Jul 05; 112(1):39-47.
Score: 0.008
-
Strickberger SA, Conti J, Daoud EG, Havranek E, Mehra MR, Pi?a IL, Young J. Patient selection for cardiac resynchronization therapy: from the Council on Clinical Cardiology Subcommittee on Electrocardiography and Arrhythmias and the Quality of Care and Outcomes Research Interdisciplinary Working Group, in collaboration with the Heart Rhythm Society. Circulation. 2005 Apr 26; 111(16):2146-50.
Score: 0.008
-
Krantz MJ, Havranek EP, Mehler PS, Haynes DK, Long CS. Impact of a cardiac risk reduction program in vulnerable patients hospitalized with coronary artery disease. Pharmacotherapy. 2004 Jun; 24(6):768-75.
Score: 0.008
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|